{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T19:24:27Z","timestamp":1791919467884,"version":"4.3.4"},"reference-count":16,"publisher":"Springer Science and Business Media LLC","issue":"1","funder":[{"DOI":"10.13039\/501100001505","name":"Health Research Council of New Zealand","doi-asserted-by":"publisher","award":["11\/203"],"award-info":[{"award-number":["11\/203"]}],"id":[{"id":"10.13039\/501100001505","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Arthritis Res Ther"],"published-print":{"date-parts":[[2017,12]]},"DOI":"10.1186\/s13075-017-1491-x","type":"journal-article","created":{"date-parts":[[2017,12,21]],"date-time":"2017-12-21T07:55:38Z","timestamp":1513842938000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":31,"title":["The effect of kidney function on the urate lowering effect and safety of increasing allopurinol above doses based on creatinine clearance: a post hoc analysis of a randomized controlled trial"],"prefix":"10.1186","volume":"19","author":[{"given":"Lisa K.","family":"Stamp","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter T.","family":"Chapman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Murray","family":"Barclay","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anne","family":"Horne","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher","family":"Frampton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul","family":"Tan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jill","family":"Drake","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicola","family":"Dalbeth","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2017,12,21]]},"reference":[{"issue":"10","key":"1491_CR1","doi-asserted-by":"crossref","first-page":"1431","DOI":"10.1002\/acr.21772","volume":"64","author":"D Khanna","year":"2012","unstructured":"Khanna D, Fitzgerald J, Khanna P, Sangmee B, Singh M, Neogi T, Pillinger M, Merill J, Lee S, Prakash S, et al. 2012 American College of Rheumatology guidelines for the management of gout. Part 1: Systematic nonpharmacologic and pharmacologic therapeutic approaches to hyperuricaemia. Arthritis Care Res. 2012;64(10):1431\u201346.","journal-title":"Arthritis Care Res"},{"issue":"1","key":"1491_CR2","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1136\/annrheumdis-2016-209707","volume":"76","author":"P Richette","year":"2017","unstructured":"Richette P, Doherty M, Pascual E, Barskova V, Becce F, Castaneda-Sanabria J, Coyfish M, Guillo S, Janesen T, Janssens H, et al. 2016 updated EULAR evidence-based recommendations for the management of gout. Ann Rheum Dis. 2017;76(1):29\u201342.","journal-title":"Ann Rheum Dis"},{"key":"1491_CR3","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/0002-9343(84)90743-5","volume":"76","author":"K Hande","year":"1984","unstructured":"Hande K, Noone R, Stone W. Severe allopurinol toxicity. Description and guidelines for prevention in patients with renal insufficiency. Am J Med. 1984;76:47\u201356.","journal-title":"Am J Med"},{"issue":"4","key":"1491_CR4","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1038\/nrrheum.2015.132","volume":"12","author":"L Stamp","year":"2016","unstructured":"Stamp L, Day R, Yun J. Allopurinol hypersensitivity: investigating the cause and minimizing the risk. Nat Rev Rheum. 2016;12(4):235\u201342.","journal-title":"Nat Rev Rheum"},{"issue":"8","key":"1491_CR5","doi-asserted-by":"crossref","first-page":"2529","DOI":"10.1002\/art.34488","volume":"64","author":"L Stamp","year":"2012","unstructured":"Stamp L, Taylor W, Jones P, Dockerty J, Drake J, Frampton C, Dalbeth N. Starting dose, but not maximum maintenance dose, is a risk factor for allopurinol hypersensitivity syndrome: a proposed safe starting dose of allopurinol. Arthritis Rheum. 2012;64(8):2529\u201336.","journal-title":"Arthritis Rheum"},{"issue":"12","key":"1491_CR6","doi-asserted-by":"crossref","first-page":"2157","DOI":"10.1136\/annrheumdis-2014-205577","volume":"74","author":"W-H Chung","year":"2015","unstructured":"Chung W-H, Chang W-C, Stocker S, Juo C-G, Graham G, Lee M-H, Williams KM, Tian YC, Juan KC, Jan Wu YJ, Yang C-H, et al. Insights into the poor prognosis of allopurinol-induced severe cutaneous adverse reactions: the impact of renal insufficiency, high plasma levels of oxypurinol and granulysin. Ann Rheum Dis. 2015;74(12):2157\u201364.","journal-title":"Ann Rheum Dis"},{"key":"1491_CR7","doi-asserted-by":"crossref","first-page":"2450","DOI":"10.1056\/NEJMoa050373","volume":"353","author":"M Becker","year":"2005","unstructured":"Becker M, Schumacher HR, Wortmann R, MacDonald P, Eustace D, Palo W, Streit J, Joseph-Ridge N. Febuxostat compared with allopurinol in patients with hyperuricaemia and gout. N Engl J Med. 2005;353:2450\u201361.","journal-title":"N Engl J Med"},{"issue":"7","key":"1491_CR8","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1001\/jama.2011.1169","volume":"306","author":"J Sundy","year":"2011","unstructured":"Sundy J, Baraf H, Yood R, Edwards N, Gutierrez-Urena S, Treadwell E, V\u00e1zquez-Mellado J, White W, Lipsky P, Horowitz Z, et al. Efficacy and tolerability of pegloticase for the treatment of chronic gout in patients refractory to conventional treatment: two randomized controlled trials. JAMA. 2011;306(7):711\u201320.","journal-title":"JAMA"},{"issue":"1","key":"1491_CR9","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1002\/art.39840","volume":"69","author":"K Saag","year":"2017","unstructured":"Saag K, Fitz-Patrick D, Kopicko J, Fung M, Bhakta N, Adler S, Storgard C, Baumgartner S, Becker M. Lesinurad combined with allopurinol: randomized, double-blind, placebo-controlled study in gout subjects with inadequate response to standard of care allopurinol (a US-based study). Arthritis Rheum. 2017;69(1):203\u201312.","journal-title":"Arthritis Rheum"},{"key":"1491_CR10","doi-asserted-by":"crossref","first-page":"1522","DOI":"10.1136\/annrheumdis-2016-210872","volume":"76","author":"L Stamp","year":"2017","unstructured":"Stamp L, Chapman P, Barclay M, Horne A, Frampton C, Tan P, Drake J, Dalbeth N. A randomised controlled trial of the efficacy and safety of allopurinol dose escalation to achieve target serum urate in people with gout. Ann Rheum Dis. 2017;76:1522\u20138.","journal-title":"Ann Rheum Dis"},{"issue":"12","key":"1491_CR11","doi-asserted-by":"crossref","first-page":"2065","DOI":"10.1136\/annrheumdis-2017-211873","volume":"76","author":"L Stamp","year":"2017","unstructured":"Stamp L, Chapman P, Barclay M, Horne A, Frampton C, Tan P, Drake J, Dalbeth N. Allopurinol dose escalation to achieve serum urate below 6\u00a0mg\/dl: an open label extension study. Ann Rheum Dis. 2017;76(12):2065\u201370.","journal-title":"Ann Rheum Dis"},{"issue":"3","key":"1491_CR12","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1002\/art.1780200320","volume":"20","author":"S Wallace","year":"1977","unstructured":"Wallace S, Robinson H, Masi A, Decker J, McCarty D, Yu T. Preliminary criteria for the classification of the acute arthritis of primary gout. Arthritis Rheum. 1977;20(3):895\u2013900.","journal-title":"Arthritis Rheum"},{"issue":"8","key":"1491_CR13","doi-asserted-by":"crossref","first-page":"2035","DOI":"10.1002\/art.39654","volume":"68","author":"K Saag","year":"2016","unstructured":"Saag K, Whelton A, Becker M, MacDonald P, Hunt B, Gunawardhana L. Impact of febuxostat on renal function in gout subjects with moderate-to-severe renal impairment. Arthritis Rheum. 2016;68(8):2035\u201343.","journal-title":"Arthritis Rheum"},{"key":"1491_CR14","doi-asserted-by":"crossref","unstructured":"Vargas-Santos AB, Neogi T. Management of gout and hyperuricaemia in CKD. Am J Kidney Dis. 2017. https:\/\/doi.org\/10.1053\/j.ajkd.2017.01.055.","DOI":"10.1053\/j.ajkd.2017.01.055"},{"issue":"45","key":"1491_CR15","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1016\/j.semarthrit.2015.05.005","volume":"2015","author":"M Becker","year":"2015","unstructured":"Becker M, Fitz-Patrick D, Choi H, Dalbeth N, Storgarde C, Cravetsf M, Baumgartner S. An open-label, 6-month study of allopurinol safety in gout: the LASSO study. Semin Arthritis Rheum. 2015;2015(45):174\u201383.","journal-title":"Semin Arthritis Rheum"},{"issue":"8","key":"1491_CR16","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1016\/j.amjcard.2015.01.529","volume":"115","author":"T Gupta","year":"2015","unstructured":"Gupta T, Harikrishnan P, Kolte D, Khera S, Subramanian K, Mujib M, Masud A, Palaniswamy C, Sule S, Jain D, et al. Trends in management and outcomes of ST-elevation myocardial infarction in patients with end-stage renal disease in the United States. Am J Cardiol. 2015;115(8):1033\u201341.","journal-title":"Am J Cardiol"}],"container-title":["Arthritis Research & Therapy"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13075-017-1491-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2017,12,21]],"date-time":"2017-12-21T07:55:54Z","timestamp":1513842954000},"score":1,"resource":{"primary":{"URL":"https:\/\/arthritis-research.biomedcentral.com\/articles\/10.1186\/s13075-017-1491-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,12]]},"references-count":16,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2017,12]]}},"alternative-id":["1491"],"URL":"https:\/\/doi.org\/10.1186\/s13075-017-1491-x","relation":{},"ISSN":["1478-6362"],"issn-type":[{"value":"1478-6362","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,12]]},"article-number":"283"}}